Zidesamtinib
Zidesamtinib entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Tue, 04 Aug 2026 16:44:58 GMTFDA Approval of Zidesamtinib for ROS1-Positive NSCLC – IASLC - Oncodaily
Wed, 29 Jul 2026 07:00:00 GMTFDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions - Memorial Sloan Kettering Cancer Center
Related explainers
Connected entities
Positive NSCLC2 live mentionsLung Cancers With2 live mentionsMemorial Sloan Kettering2 live mentionsFDA Approval1 live mentionsIASLC1 live mentionsOncodaily FDA Approval1 live mentionsIASLC Oncodaily Oncodaily1 live mentionsFDA Approves Zidesamtinib1 live mentionsFusions1 live mentionsCancer Center FDA1 live mentions
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Zidesamtinib.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
2 distinct publisher/source names are currently connected to this entity page.